JP2012516315A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012516315A5 JP2012516315A5 JP2011546961A JP2011546961A JP2012516315A5 JP 2012516315 A5 JP2012516315 A5 JP 2012516315A5 JP 2011546961 A JP2011546961 A JP 2011546961A JP 2011546961 A JP2011546961 A JP 2011546961A JP 2012516315 A5 JP2012516315 A5 JP 2012516315A5
- Authority
- JP
- Japan
- Prior art keywords
- aqueous composition
- nitric oxide
- composition according
- nitrite
- component comprises
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 20
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 claims 18
- 238000004519 manufacturing process Methods 0.000 claims 5
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 claims 4
- 201000004681 Psoriasis Diseases 0.000 claims 3
- 239000003638 chemical reducing agent Substances 0.000 claims 3
- 150000003573 thiols Chemical group 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 1
- 230000002378 acidificating effect Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 claims 1
- 238000011065 in-situ storage Methods 0.000 claims 1
- PJUIMOJAAPLTRJ-UHFFFAOYSA-N monothioglycerol Chemical compound OCC(O)CS PJUIMOJAAPLTRJ-UHFFFAOYSA-N 0.000 claims 1
- 150000002826 nitrites Chemical class 0.000 claims 1
- ICRHORQIUXBEPA-UHFFFAOYSA-N thionitrous acid Chemical compound SN=O ICRHORQIUXBEPA-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0901456.4A GB0901456D0 (en) | 2009-01-29 | 2009-01-29 | Treatment of psoriasis |
| GB0901456.4 | 2009-01-29 | ||
| PCT/GB2010/050091 WO2010086637A1 (en) | 2009-01-29 | 2010-01-22 | Treatment of psoriasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2012516315A JP2012516315A (ja) | 2012-07-19 |
| JP2012516315A5 true JP2012516315A5 (enExample) | 2013-02-14 |
Family
ID=40469254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011546961A Pending JP2012516315A (ja) | 2009-01-29 | 2010-01-22 | 乾癬の処置 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20110287113A1 (enExample) |
| EP (1) | EP2391356A1 (enExample) |
| JP (1) | JP2012516315A (enExample) |
| KR (1) | KR20110120287A (enExample) |
| CN (1) | CN102369004A (enExample) |
| AU (1) | AU2010209455A1 (enExample) |
| BR (1) | BRPI1007543A2 (enExample) |
| CA (1) | CA2750758A1 (enExample) |
| GB (1) | GB0901456D0 (enExample) |
| RU (1) | RU2011135741A (enExample) |
| WO (1) | WO2010086637A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2678069A4 (en) * | 2011-02-25 | 2015-03-25 | Univ Windsor | DEVICE FOR CONTROLLED RELEASE OF TOPICAL STAIN OXIDE |
| JP6608382B2 (ja) * | 2014-02-26 | 2019-11-20 | ルマ セラピューティクス，インク． | 紫外光治療装置及び方法 |
| ITUB20154719A1 (it) | 2015-10-21 | 2017-04-21 | Glano Tech Ltd | Formulazione per il rilascio di ossido nitrico |
| CN109310527A (zh) | 2016-02-09 | 2019-02-05 | 鲁玛治疗公司 | 用于通过光疗法来治疗牛皮癣的方法、组合物和设备 |
| US10716805B2 (en) * | 2018-03-19 | 2020-07-21 | Glanotech Limited | Formulation for release of nitric oxide |
| GB2588748A (en) * | 2019-10-07 | 2021-05-12 | Insense Ltd | Composition for delivering nitric oxide to skin |
| BR112022005166A2 (pt) * | 2019-10-07 | 2022-06-14 | Insense Ltd | Composição de aplicação à pele |
| KR102333779B1 (ko) * | 2020-02-03 | 2021-12-03 | 주식회사 큐라젠 | 산화질소 플라즈마를 이용한 돌출형 폴리우레탄 드레싱폼 및 그 제조 방법 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4305881C1 (de) * | 1993-02-26 | 1994-03-03 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Wirkstoffen, welche Stichoxid-Quellen darstellen, Verfahren zu seiner Herstellung sowie seine Verwendung |
| US7052711B2 (en) * | 1999-09-02 | 2006-05-30 | Rice University | Nitric oxide-producing hydrogel materials |
| US20030147835A1 (en) | 2000-06-15 | 2003-08-07 | Munro Hugh Semple | Process for the manufacture of hydrogel compositions and hydrogel compositions manufactured thereby |
| GB0021317D0 (en) * | 2000-08-30 | 2000-10-18 | Queen Mary & Westfield College | Transdermal pharmaceutical delivery composition |
| EP1693073B1 (en) | 2002-04-24 | 2014-07-23 | Archimed LLP | Wound dressings comprising hydrated hydrogels and enzymes |
| US20040062793A1 (en) * | 2002-07-05 | 2004-04-01 | Dyke Mark Van | Tissue defect dressings comprising proteinaceous networks |
| US20070059351A1 (en) * | 2003-10-17 | 2007-03-15 | Murrell George A C | Transdermal patches containing a nitric oxide-donor and a second active agent and associated methods |
| MX2007009691A (es) * | 2005-02-11 | 2008-02-12 | Nolabs Ab | Dispositivo y metodo para el tratamiento de dermatomicosis y, en particular, de onicomicosis. |
| EP1690558A1 (en) * | 2005-02-11 | 2006-08-16 | NOLabs AB | Device for treatment of diabetic disorders |
| EP1846009A2 (en) * | 2005-02-11 | 2007-10-24 | NOLabs AB | Improved device for application of medicaments, manufacturing method therefor, and method of treatment |
| GB0505035D0 (en) * | 2005-03-11 | 2005-04-20 | Insense Ltd | Improvements relating to skin dressings |
| EP1704876A1 (en) * | 2005-03-24 | 2006-09-27 | NOLabs AB | Cosmetic treatment, device for performing said treatment and manufacturing method thereof |
| GB0616350D0 (en) * | 2006-08-17 | 2006-09-27 | Univ St Andrews | Adsorption and release of nitric oxide in metal organic frameworks |
| US20080206364A1 (en) * | 2006-10-13 | 2008-08-28 | Nitric Biotherapeutics, Inc. | Topical nitric oxide as a treatment of autoimmune diseases |
| GB0715554D0 (en) | 2007-08-09 | 2007-09-19 | Insense Ltd | Improvements relating to skin dressings |
-
2009
- 2009-01-29 GB GBGB0901456.4A patent/GB0901456D0/en not_active Ceased
-
2010
- 2010-01-22 BR BRPI1007543A patent/BRPI1007543A2/pt not_active IP Right Cessation
- 2010-01-22 CN CN2010800142892A patent/CN102369004A/zh active Pending
- 2010-01-22 US US13/146,725 patent/US20110287113A1/en not_active Abandoned
- 2010-01-22 CA CA2750758A patent/CA2750758A1/en not_active Abandoned
- 2010-01-22 WO PCT/GB2010/050091 patent/WO2010086637A1/en not_active Ceased
- 2010-01-22 JP JP2011546961A patent/JP2012516315A/ja active Pending
- 2010-01-22 AU AU2010209455A patent/AU2010209455A1/en not_active Abandoned
- 2010-01-22 EP EP10702163A patent/EP2391356A1/en not_active Withdrawn
- 2010-01-22 KR KR1020117018765A patent/KR20110120287A/ko not_active Withdrawn
- 2010-01-22 RU RU2011135741/15A patent/RU2011135741A/ru not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012516315A5 (enExample) | ||
| DK2173391T3 (da) | Forbedringer vedrørende hudforbindinger | |
| RU2011135741A (ru) | Лечение псориаза | |
| DE602008004643D1 (de) | 1-ä2-(2,4-dimethylphenylsulfanyl)phenylüpiperazin als verbindung mit kombinierter serotonin-aufnahme, 5-ht3- und 5-ht1a-aktivität zur behandlung von schmerzen oder restsymptomen bei depressionen im zusammenhang mt schlaf und kognition | |
| PE20151727A1 (es) | Acido 2-aza-biciclo[2.2.1]heptano-3-carboxilico (bencil-ciano-metil)-amidas sustituidas inhibidores de catepsina c | |
| DE602007012024D1 (de) | Regelungsverfahren für die Eluierung von therapeutischen Wirkstoffen | |
| WO2010091376A3 (en) | Devices and methods for perfusion therapy | |
| EA201100335A1 (ru) | Производные пурина для применения при лечении связанных с fab заболеваний | |
| MX2013013809A (es) | Dispositivos expandibles con revestimiento de una composicion de paclitaxel. | |
| JP2012517420A5 (enExample) | ||
| ZA201209289B (en) | Urea derivatives and their therapeutic use in the treatment of,inter alia,diseases of the respiratory tract | |
| MX365688B (es) | Sistemas de administracion de farmaco y metodos para el tratamiento del cancer de vejiga que comprenden oxaliplatino. | |
| CY1111547T1 (el) | Συνδυασμος zd6474 και πεμετρεξεδης | |
| MX367070B (es) | Sistemas de administracion de farmaco y metodos para el tratamiento de la prostata. | |
| WO2014191738A8 (en) | Degradable haemostat composition | |
| EA201390745A1 (ru) | Активируемая пользователем автономная выполненная в едином корпусе система доставки лекарственного средства посредством ионофореза | |
| MX2013008175A (es) | Composiciones farmacéuticas para suministro tópico de fotosensibilizadores y usos de los mismos. | |
| CY1111482T1 (el) | Συνδυασμος azd2171 και πεμετρεξεδης | |
| WO2012051614A3 (en) | Delivery of hydrophobic bioactive agents | |
| MX382776B (es) | Uso de levocetirizina y montelukast en el tratamiento de lesion traumatica. | |
| MX377510B (es) | Uso de levocetirizina y montelukast en el tratamiento de anafilaxis. | |
| BR112013019680A2 (pt) | combinações compreendendo macitentana para o tratamento de glioblastoma multiforme | |
| MX2013013808A (es) | Dispositivos expandibles con revestimiento de una composicion de rapamicina. | |
| WO2006053788A3 (en) | Alterations in seborrheic keratoses and their applications | |
| EP2578232A4 (en) | TREATMENT FOR AUTOIMMUN DISEASES AND ALLERGIC DISEASES |